Effects of endocrine disruptors in the development of the female reproductive tract
Carregando...
Citações na Scopus
84
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
Autores
Citação
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, v.58, n.2, Special Issue, p.153-161, 2014
Resumo
Environmental agencies have identified a growing number of environmental contaminants that have endocrine disrupting activity, and these can become a major public health problem. It is suggested that endocrine disruptors could account for the higher-than-expected increase in the prevalence of some non-communicable diseases, such as obesity, diabetes, thyroid diseases, and some cancers. Several endocrine Disrupting Chemicals (EDCs), such as pesticides, bisphenol A, phthalates, dioxins, and phytoestrogens, can interact with the female reproductive system and lead to endocrine disruption. Initially, it was assumed that EDCs exert their effects by binding to hormone receptors and transcription factors, but it is currently known that they may also alter the expression of enzymes involved in the synthesis or catabolism of steroids. Biomonitoring studies have identified these compounds in adults, children, pregnant women, and fetuses. Among the diseases of the female reproductive tract associated with EDCs exposure are the following: precocious puberty, polycystic ovary syndrome, and premature ovarian failure. The different populations of the world are exposed to a great number of chemicals through different routes of infection; despite the various available studies, there is still much doubt regarding the additive effect of a mixture of EDCs with similar mechanisms of action.
Palavras-chave
Endocrine disruptors, female development, precocious puberty, polycystic ovary syndrome, premature ovarian failure
Referências
- Ahn HJ, 2012, MOL REPROD DEV, V79, P626, DOI 10.1002/mrd.22070
- Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8451
- Axmon A, 2004, CHEMOSPHERE, V56, P813, DOI 10.1016/j.chemosphere.2004.03.002
- Bachega TASS, 2011, ARQ BRAS ENDOCRINOL, V55, P175, DOI 10.1590/S0004-27302011000200011
- Bastos AMX, 2013, ARQ BRAS ENDOCRINOL, V57, P346, DOI 10.1590/S0004-27302013000500003
- Bigsby R, 1999, ENVIRON HEALTH PERSP, V107, P613, DOI 10.2307/3434553
- Brieno-Enriquez MA, 2012, MOL HUM REPROD, V18, P171, DOI 10.1093/molehr/gar074
- Buttke DE, 2012, ENVIRON HEALTH PERSP, V120, P1613, DOI 10.1289/ehp.1104748
- Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200
- Chang JW, 2010, EPIDEMIOLOGY, V21, P56, DOI 10.1097/EDE.0b013e3181c2fc6e
- Chao HR, 2007, FOOD CHEM TOXICOL, V45, P259, DOI 10.1016/j.fct.2006.07.032
- Christensen Brock C, 2011, Front Genet, V2, P84, DOI 10.3389/fgene.2011.00084
- Cooper AR, 2011, FERTIL STERIL, V95, P1890, DOI 10.1016/j.fertnstert.2010.01.016
- Costa EMF, 2013, PROENDOCRINO, V4
- Cummings AM, 1997, CRIT REV TOXICOL, V27, P367, DOI 10.3109/10408449709089899
- Decherf S, 2011, J TOXICOL ENV HEAL B, V14, P423, DOI 10.1080/10937404.2011.578561
- Diamanti-Kandarakis E, 2008, CLIN ENDOCRINOL, V69, P634, DOI 10.1111/j.1365-2265.2008.03247.x
- Diamanti-Kandarakis E, 2009, EUR J ENDOCRINOL, V160, P847, DOI 10.1530/EJE-08-0510
- Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002
- Eichenlaub-Ritter U, 2008, MUTAT RES-GEN TOX EN, V651, P82, DOI 10.1016/j.mrgentox.2007.10.014
- Farr SL, 2004, AM J EPIDEMIOL, V160, P1194, DOI 10.1093/aje/kwi006
- Fernandez M, 2010, ENVIRON HEALTH PERSP, V118, P1217, DOI 10.1289/ehp.0901257
- Fortes EM, 2007, ARQ BRAS ENDOCRINOL, V51, P500, DOI 10.1590/S0004-27302007000300021
- Gaido KW, 2000, MOL PHARMACOL, V58, P852
- GUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198
- Hanioka N, 1998, ARCH TOXICOL, V72, P387, DOI 10.1007/s002040050518
- Hao CJ, 2012, BIOSCIENCE REP, V32, P619, DOI 10.1042/BSR20120042
- Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015
- Hoyer PB, 2001, TOXICOL PATHOL, V29, P91, DOI 10.1080/019262301301418892
- Hunt PA, 2003, CURR BIOL, V13, P546, DOI 10.1016/S0960-9822(03)00189-1
- Jinno M, 2011, HUM REPROD, V26, P604, DOI 10.1093/humrep/deq388
- Kandaraki E, 2011, J CLIN ENDOCR METAB, V96, pE480, DOI 10.1210/jc.2010-1658
- Kappeler CJ, 2012, SYST BIOL REPROD MED, V58, P57, DOI 10.3109/19396368.2011.648820
- Kirigaya A, 2009, ZOOL SCI, V26, P704, DOI 10.2108/zsj.26.704
- Liem AKD, 2000, FOOD ADDIT CONTAM, V17, P241, DOI 10.1080/026520300283324
- MARTINEZ EM, 1991, REPROD TOXICOL, V5, P139, DOI 10.1016/0890-6238(91)90042-E
- Mouritsen A, 2010, INT J ANDROL, V33, P346, DOI 10.1111/j.1365-2605.2010.01051.x
- Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697
- Newbold RR, 2004, TOXICOL APPL PHARM, V199, P142, DOI 10.1016/j.taap.2003.11.033
- Newbold RR, 2009, ENVIRON HEALTH PERSP, V117, P879, DOI 10.1289/ehp.0800045
- Nikaido Y, 2004, REPROD TOXICOL, V18, P803, DOI 10.1016/j.reprotox.2004.05.002
- Pasquali R, 2011, CLIN ENDOCRINOL, V74, P424, DOI 10.1111/j.1365-2265.2010.03956.x
- Patisaul HB, 2013, ADV EXP MED BIOL, V784, P455, DOI 10.1007/978-1-4614-6199-9_21
- Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189
- Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007
- Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165
- Uribarri J, 2006, CLIN J AM SOC NEPHRO, V1, P1293, DOI 10.2215/CJN.01270406
- Zhou W, 2008, MOL CELL ENDOCRINOL, V283, P12, DOI 10.1016/j.mce.2007.10.010
- Zoeller RT, 2006, ENDOCRINOLOGY, V147, P5513, DOI 10.1210/en.2006-1282